| Literature DB >> 35073961 |
Fengyi Liu1,2,3, Xu Wang1,2,3, Yuzhou Li1,2,3, Mingxing Ren1,2,3, Ping He1,2,3, Lu Wang1,2,3, Jie Xu4,5,6, Sheng Yang7,8,9, Ping Ji10,11,12.
Abstract
BACKGROUND: Cartilage defects pose a significant burden on medical treatment, leading to an urgent need to develop regenerative medicine approaches for cartilage repair, such as stem cell therapy. However, the direct injection of stem cells can result in insufficient delivery or inaccurate differentiation. Hence, it is necessary to choose appropriate stem cell delivery scaffolds with high biocompatibility, injectability and chondral differentiation induction ability for cartilage regeneration.Entities:
Keywords: Cartilage regeneration; GelMA; Injectable hydrogel; PAMAM; Stem cell therapy
Mesh:
Substances:
Year: 2022 PMID: 35073961 PMCID: PMC8785478 DOI: 10.1186/s13287-022-02705-6
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Fig. 1Schematic diagram of the injectable stem cell-laden photocrosslinked GelMA/PAMAM-MA hydrogel for cartilage regeneration
Fig. 2Physiochemical property analysis of GelMA/PAMAM-MA hydrogels. A Schematic illustration of the preparation of photocrosslinked GelMA/PAMAM-MA hydrogel. B FTIR spectroscopy of gelatin, GelMA, PAMAM and PAMAM-MA. C Optical images of the GelMA/PAMAM-MA hydrogel before and after 365 nm UV light irradiation. D SEM characterization pictures and statistical analysis of GelMA and GelMA/PAMAM-MA hydrogel pore sizes. Scare bars: 40 μm. E. Swelling ratio test of two groups of hydrogels. F In vitro degradation test of GelMA and GelMA/PAMAM-MA hydrogel. G Compressive modulus analysis of GelMA and GelMA/PAMAM-MA hydrogels. Error bar: Mean ± SD, * represents p < 0.05
Fig. 3Identification of rASCs and in vitro biocompatibility evaluations. A FCM analysis of the expression of stem cell identification-related antibodies in rASCs. B Representative images of the multidifferentiation ability test of rASCs. Left, ALP staining, middle, Oil red O staining, right, Alcian blue staining. Scare bars: 100 μm. C Representative images of live/dead rASCs cultured in GelMA and GelMA/PAMAM-MA hydrogels on days 1, 4 and 7. Green fluorescence indicates live cells, and red fluorescence indicates dead cells. Scare bars: 200 μm. D Representative images of phalloidin/DAPI fluorescence images of rASCs cultured in two groups of GelMA/PAMAM-MA hydrogels after 1 day, 4 days and 7 days. Green fluorescence indicates the cytoskeleton, and blue fluorescence indicates the nucleus. Scare bars: 50 μm. E Quantification of the live and dead cells. F Quantification of the cell spreading areas of rASCs cultured in two groups of hydrogels. Error bar: Mean ± SD, * represents p < 0.05
Fig. 4In vitro chondrogenic differentiation analysis of 3D-cultured rASCs. A Quantitative real-time PCR analysis of the expression of chondrogenic differentiation-related genes in rASCs encapsulated in GelMA and GelMA/PAMAM-MA hydrogels. B Representative images of safranin-O staining after 14 days of chondrogenic induction culture. Scale bars: above, 200 μm; below, 40 μm. C Representative images of immunofluorescence staining of SOX9 in rASCs encapsulated in two groups of hydrogels after 21 days of chondrogenic induction culture. Scale bars: 75 μm. D Quantification of the positively stained area of GAGs in the two groups of hydrogels. E Quantification of SOX9 expression in the two groups of hydrogels. Error bar: Mean ± SD, * represents p < 0.05
Fig. 5In vivo evaluation of cartilage repair in rats. A Schematic illustration of the surgical procedure in which rASCs were encapsulated in GelMA/PAMAM-MA hydrogel and injected into the articular cartilage defects of rats. B ICRS visual histological assessment score of the normal control group, blank control group, GelMA + rASCs group and GelMA/PAMAM-MA + rASCs group. C General views of rat knee joint specimens of the four groups obtained after repair for 8 weeks. D and E Histological images of H&E staining (D) and safranin-O/fast green staining (E) of rat cartilage defects in the four groups. Scale bars: 500 μm. Error bar: Mean ± SD, * represents p < 0.05
Fig. 6A Immunohistochemical staining of Col-II in the four experimental groups. Scare bars: 100 μm. B Immunohistochemical staining of SOX9 in the four experimental groups. Scare bars: above, 100 μm; below, 20 μm. C Quantification of Col-II expression in the four experimental groups. D Quantification of SOX9 expression in the four experimental groups. Error bar: Mean ± SD, * represents p < 0.05